Tag Archives: avanafil
Avanafil Passes Second Late-Stage Test
Vivus (VVUS) shares had a bounce this morning by the encouraging announcement of round two of late-stage data on avanafil, a erectile dysfunction drug. Within 15 minutes of two doses, avanafil showed significant improvements of erectile function and intercourse from … Continue reading